Is Citius Pharmaceuticals, Inc. technically bullish or bearish?

As of 6 August 2025, the technical trend for Citius Pharmaceuticals, Inc. has changed from sideways to mildly bearish. The weekly MACD is mildly bullish, while the monthly MACD is also mildly bullish, but the overall sentiment is tempered by bearish signals from the Bollinger Bands and daily moving averages. The RSI shows a bullish signal on the monthly timeframe but no signal on the weekly. The KST indicates a bullish stance weekly but is bearish monthly, and Dow Theory reflects a mildly bullish weekly outlook against a mildly bearish monthly view.
In terms of performance, Citius Pharmaceuticals has significantly underperformed compared to the S&P 500 across multiple periods, with a year-to-date return of -70.75% versus the S&P's 12.22%, and a one-year return of -90.82% compared to the S&P's 17.14%. Overall, the current technical stance is mildly bearish, driven primarily by the bearish daily moving averages and Bollinger Bands, despite some mixed signals from other indicators.